Canadian National Railway Company
CNR.TOTSXIndustrials● Active
$168.70
+$0.76(+0.45%)
Market Cap$102.3B
P/E Ratio—
52W High$169.9
52W Low$126.11
Canadian National Railway Company（CNR.TO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CNR.TO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $4.72B | $4.45B | $5.63B | $5.12B | $4.90B |
| Depreciation & Amort. | $1.94B | $1.89B | $1.82B | $1.73B | $1.60B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.06B | $0.00B |
| Change in Working Capital | $0.47B | $0.09B | ($0.05B) | ($0.41B) | $0.15B |
| Net Cash from Operations | $7.05B | $6.70B | $6.96B | $6.67B | $6.97B |
| Investing Activities | |||||
| Capital Expenditure | ($3.66B) | ($3.55B) | ($3.19B) | ($2.75B) | ($2.89B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($3.71B) | ($3.61B) | ($3.47B) | ($2.51B) | ($2.87B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($2.12B) | ($2.65B) | ($4.63B) | ($4.84B) | ($1.64B) |
| Dividends Paid | ($2.21B) | ($2.14B) | ($2.07B) | ($2.00B) | ($1.74B) |
| Debt Issued / Repaid | $0.91B | $1.06B | $3.21B | $1.52B | ($0.39B) |
| Net Cash from Financing | ($3.37B) | ($3.62B) | ($3.41B) | ($4.67B) | ($3.86B) |
| Free Cash Flow | |||||
| Free Cash Flow | $3.39B | $3.15B | $3.78B | $3.92B | $4.08B |
| FCF Margin %(computed) | 19.60% | 18.48% | 22.45% | 22.90% | 28.18% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · CAD · B
深入了解Canadian National Railway Company
关于Canadian National Railway Company（CNR.TO）现金流量表
Canadian National Railway Company 2025财年经营活动现金流$7.05B，自由现金流$3.39B（FCF利润率19.60%），资本支出($3.66B)。
常见问题
CNR.TO · 4 问Canadian National Railway Company 2025财年自由现金流$3.39B，同比up7.7%。
CNR.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10